Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1011423

	registered interest
	date	21/11/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Mental Health Services: Finance
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the report entitled Fair funding for mental health: Putting parity into practice, published by IPPR in October 2018, if he will make an assessment of the implications for his policies of the finding in that report that NHS mental health services require an increase in spending of at least (a) five per cent up to 2023-24 and (b) 5.5 per cent by 2030-31 to achieve parity of esteem.
	tabling member constituency	Brighton, Kemptown
	tabling member printed	Lloyd Russell-Moyle
	uin	194122
	answer	answer is ministerial correction date of answer 28/11/2018 answer text <p>The Government recognises the need for additional investment in mental health services and the Institute for Public Policy Research report represents a valuable contribution to the debate.</p><p> </p><p>The Government announced its long term financial settlement for the National Health Service in June. This will represent an increase of £20.5 billion in real terms by 2023/24 and the chancellor has already announced that at least a further £2 billion of this will go to fund mental health, including expanding crisis services and supporting more people with severe mental illness into employment.</p><p> </p><p>The Government has asked the NHS to develop a long term plan which will set out a vision for the health service and ensure every penny is well spent. The Government has been clear that better access to mental health services, to help achieve the Government’s commitment to parity of esteem between mental and physical health, is one of the principles which must underpin the plan. Further details will follow when the plan is published in due course.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 28/11/2018 14:22:14 answering member 4065 label Biography information for Dame Jackie Doyle-Price
	tabling member	4615 label Biography information for Lloyd Russell-Moyle

1011452

	registered interest
	date	21/11/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Incinerators: Health Hazards
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether Public Health England has made an assessment of the financial cost to society of emissions from waste incinerators.
	tabling member constituency	Stroud
	tabling member printed	Dr David Drew
	uin	194030
	answer	answer is ministerial correction date of answer 29/11/2018 answer text <p>Public Health England (PHE) has not made an assessment of the financial cost to society of emissions from waste incinerators. PHE’s position is that well run and regulated modern municipal waste incinerators are not a significant risk to public health.</p><p> </p><p>Waste management facilities are regulated in England by the Environment Agency (EA) under the Environmental Permitting (England and Wales) Regulations 2010. When consulted, PHE provides an expert and independent opinion to the regulator (EA) on the potential impacts on human health of emissions arising from existing or proposed regulated facilities. PHE will comment on the applicants’ risk assessments and how they demonstrate the installation’s impacts on human health, and when requested, any additional modelling and assessments conducted by the EA, providing health advice that is clear, concise and based on best available evidence and expert judgement.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 194037 question first answered 29/11/2018 14:13:49 answering member 4067 label Biography information for Steve Brine
	tabling member	252 label Biography information for Dr David Drew

1011473

	registered interest
	date	21/11/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Mental Illness: Children
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what estimate he has made of the number of under-16s who have regular prescriptions for medication due to long-term mental health conditions.
	tabling member constituency	Coventry South
	tabling member printed	Mr Jim Cunningham
	uin	194034
	answer	answer is ministerial correction date of answer 26/11/2018 answer text <p>No such estimate has been made. Prescription forms do not include a clinical indication, therefore it is not possible to identify prescription items dispensed to treat mental health conditions.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 26/11/2018 17:49:38 answering member 4067 label Biography information for Steve Brine
	tabling member	308 label Biography information for Mr Jim Cunningham

1011474

	registered interest
	date	21/11/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Mental Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the adequacy of access to mental health services for individuals who have been involved in a terror attack.
	tabling member constituency	Vale of Clwyd
	tabling member printed	Chris Ruane
	uin	194066
	answer	answer is ministerial correction date of answer 26/11/2018 answer text <p>The Government and its health partners recognise that it is important to ensure that people who have survived any form of critical incident have appropriate, evidence based mental health support if needed.</p><p> </p><p>It is essential that the mental health response is proportionate to the situation and the specific models of service delivery are a matter for NHS England and the local National Health Service.</p><p> </p><p>We are aware that health systems in London and Manchester are evaluating the response of the NHS and wider economy to their recent terrorist events. We will ensure this learning is shared with the system.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 26/11/2018 17:27:05 answering member 4065 label Biography information for Dame Jackie Doyle-Price
	tabling member	534 label Biography information for Chris Ruane

1011502

	registered interest
	date	21/11/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Disability: Children
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what plans he has to improve the quality of health and social care services for disabled children.
	tabling member constituency	Kingston upon Hull West and Hessle
	tabling member printed	Emma Hardy
	uin	194150
	answer	answer is ministerial correction date of answer 28/11/2018 answer text <p>In 2014, the Government introduced a new statutory framework requiring local authorities and clinical commissioning groups to commission jointly services for children with special educational needs and disability, across health, social care and education. Since 2014, £327 million has been given to local areas to support implementation of these new arrangements, in addition to the high needs budget for placements for pupils with complex special educational needs.</p><p> </p><p>In addition to their role inspecting providers, Ofsted and the Care Quality Commission are jointly inspecting every local area’s arrangements. The inspections assess the effectiveness of joint arrangements by commissioners of health, education and social care to support children with special educational needs, with written statements of action required where improvement is needed.</p><p> </p><p>Improving wheelchair access for children has been included as a ‘must do’ in NHS England’s planning guidance for clinical commissioning groups (CCGs) for 2017/18 – 2018/19, which was issued in September 2016. Each CCG is required to set out improvement plans showing how they would halve the number of children waiting 18 weeks by Q4 2017/18 and eliminate 18 week waits for wheelchairs by the end of 2018/19.</p><p> </p><p>In April 2018, we announced investment of £1.5 million in child sports prostheses across 2018/19 and 2019/20 for the provision of child sports protheses and research.</p><p> </p><p>In 2019 we will be consulting on introducing mandatory learning disability training for health and care staff.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 28/11/2018 14:19:55 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	4645 label Biography information for Emma Hardy

1011507

	registered interest
	date	21/11/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Breast Cancer: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential effect of delays in drug supply chains on access to medicines for breast cancer patients in the event that the UK leaves the EU without a deal.
	tabling member constituency	Neath
	tabling member printed	Christina Rees
	uin	194155
	answer	answer is ministerial correction date of answer 28/11/2018 answer text <p>On 23 August 2018 the Department wrote to all pharmaceutical companies that supply the United Kingdom with prescription only or pharmacy medicines from, or via, the European Union/European Economic Area, asking them to ensure they have a minimum of six weeks’ additional supply in the UK, over and above their business as usual operational buffer stocks, by 29 March 2019 in the unlikely the event that the UK were to leave the EU without a deal.</p><p> </p><p>Since then, we have received very good engagement from industry who share our aims of ensuring continuity of medicines supply for patients is maintained and able to cope with any potential delays at the border that may arise in the short term in the event of a no-deal Brexit.</p><p> </p><p>We understand medicines for breast cancer patients are vitally important to many people in this country. However, the Department recognises that through its medicines supply contingency programme, it is requesting sensitive commercial information from pharmaceutical companies. To reassure participating companies, we have committed to treating all information received confidentially, securely and to using it only for the purposes of the Department’s programme. That means not introducing information about a company, specific medicine or their supply routes into the public domain.</p> answering member constituency Wimbledon answering member printed Stephen Hammond grouped question UIN 194160 question first answered 28/11/2018 14:02:20 answering member 1585 label Biography information for Stephen Hammond
	tabling member	4525 label Biography information for Christina Rees

1011508

	registered interest
	date	21/11/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Maternity Services: Fees and Charges
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the number of women who do not access maternity care because of concerns about NHS charging policies.
	tabling member constituency	Birmingham, Hall Green
	tabling member printed	Mr Roger Godsiff
	uin	194039
	answer	answer is ministerial correction date of answer 29/11/2018 answer text <p>The Department has recently reviewed the impact of changes introduced by the Amendment Regulations with a particular focus on the extent to which there are any unintended consequences for the most vulnerable. The outcomes of this review will be published in due course.</p><p> </p><p>The Department does not collect data on the number of women who do not access maternity care because of concerns about National Health Service charging policies.</p><p> </p><p>The national guidance is clear that NHS maternity treatment should always be considered as immediately necessary and provided to all patients regardless of whether or not they are entitled to receive it free of charge or there are doubts about whether they could pay if subsequently found to be chargeable under the National Health Service (Charges to Overseas Visitors) Regulations 2015, as amended.</p><p> </p><p>Providers of NHS care need to ensure that they take necessary and appropriate steps to recover the cost of providing treatment to those not entitled to NHS-funded care. National guidance recommends that providers of NHS care should consider employing the services of a debt recovery agency that specialises in the recovery of overseas debt except in relation to persons whom it is clear to the relevant body will be unable to pay.</p> answering member constituency Wimbledon answering member printed Stephen Hammond grouped question UIN 194046 194047 question first answered 29/11/2018 13:59:45 answering member 1585 label Biography information for Stephen Hammond
	tabling member	304 label Biography information for Mr Roger Godsiff

1011510

	registered interest
	date	21/11/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what advice he has issued to manufacturers of general sales list medicines on whether to stockpile medicines in preparation for the UK leaving the EU without a deal; whether he plans to update that advice before the end of 2018; and if he will make a statement.
	tabling member constituency	Darlington
	tabling member printed	Jenny Chapman
	uin	194157
	answer	answer is ministerial correction date of answer 26/11/2018 answer text <p>On 23 August 2018 the Department wrote to all pharmaceutical companies that supply the United Kingdom with pharmacy (P) or prescription-only medicines (POM) from, or via, the European Union/European Economic Area (EEA), asking them to ensure they have a minimum of six weeks’ additional supply in the UK, over and above their business as usual operational buffer stocks, by 29 March 2019 in the event of a no deal EU Exit.</p><p> </p><p>Over-the-counter ‘General Sales List’ (GSL) medicines are not included in the Department’s medicines supply contingency programme. GSLs are not considered in-scope for the programme as there are multiple alternatives available should a single GSL medicine be subject to a short-term supply disruption.</p><p> </p><p>The Department is currently considering how best it may support pharmaceutical companies as part of its medicine supply contingency programme. Part of this support will include funding to provide additional capacity for the storage of P and POM medicines in the UK. A process to apply for such funding has been undertaken in recent weeks and contract agreements are imminent.</p> answering member constituency Wimbledon answering member printed Stephen Hammond grouped question UIN 194158 194159 question first answered 26/11/2018 16:08:43 answering member 1585 label Biography information for Stephen Hammond
	tabling member	3972 label Biography information for Baroness Chapman of Darlington

1011511

	registered interest
	date	21/11/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what estimate he has made of the number of people presenting at NHS services because they are unable to purchase general sales list medicines for (a) themselves and (b) their children in the event that the UK leaves the EU without a deal; and if he will make a statement.
	tabling member constituency	Darlington
	tabling member printed	Jenny Chapman
	uin	194158
	answer	answer is ministerial correction date of answer 26/11/2018 answer text <p>On 23 August 2018 the Department wrote to all pharmaceutical companies that supply the United Kingdom with pharmacy (P) or prescription-only medicines (POM) from, or via, the European Union/European Economic Area (EEA), asking them to ensure they have a minimum of six weeks’ additional supply in the UK, over and above their business as usual operational buffer stocks, by 29 March 2019 in the event of a no deal EU Exit.</p><p> </p><p>Over-the-counter ‘General Sales List’ (GSL) medicines are not included in the Department’s medicines supply contingency programme. GSLs are not considered in-scope for the programme as there are multiple alternatives available should a single GSL medicine be subject to a short-term supply disruption.</p><p> </p><p>The Department is currently considering how best it may support pharmaceutical companies as part of its medicine supply contingency programme. Part of this support will include funding to provide additional capacity for the storage of P and POM medicines in the UK. A process to apply for such funding has been undertaken in recent weeks and contract agreements are imminent.</p> answering member constituency Wimbledon answering member printed Stephen Hammond grouped question UIN 194157 194159 question first answered 26/11/2018 16:08:44 answering member 1585 label Biography information for Stephen Hammond
	tabling member	3972 label Biography information for Baroness Chapman of Darlington

1011512

	registered interest
	date	21/11/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether he plans to offer financial support to manufacturers of general sales list medicines for the stockpiling of medicines in preparation for the UK leaving the EU without a deal.
	tabling member constituency	Darlington
	tabling member printed	Jenny Chapman
	uin	194159
	answer	answer is ministerial correction date of answer 26/11/2018 answer text <p>On 23 August 2018 the Department wrote to all pharmaceutical companies that supply the United Kingdom with pharmacy (P) or prescription-only medicines (POM) from, or via, the European Union/European Economic Area (EEA), asking them to ensure they have a minimum of six weeks’ additional supply in the UK, over and above their business as usual operational buffer stocks, by 29 March 2019 in the event of a no deal EU Exit.</p><p> </p><p>Over-the-counter ‘General Sales List’ (GSL) medicines are not included in the Department’s medicines supply contingency programme. GSLs are not considered in-scope for the programme as there are multiple alternatives available should a single GSL medicine be subject to a short-term supply disruption.</p><p> </p><p>The Department is currently considering how best it may support pharmaceutical companies as part of its medicine supply contingency programme. Part of this support will include funding to provide additional capacity for the storage of P and POM medicines in the UK. A process to apply for such funding has been undertaken in recent weeks and contract agreements are imminent.</p> answering member constituency Wimbledon answering member printed Stephen Hammond grouped question UIN 194157 194158 question first answered 26/11/2018 16:08:43 answering member 1585 label Biography information for Stephen Hammond
	tabling member	3972 label Biography information for Baroness Chapman of Darlington